INTERPACE BIOSCIENCES, INC. (IDXG) › Operating IncomeINTERPACE BIOSCIENCES, INC. (IDXG) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$6.90M2011: -$4.70M2012: -$25.23M2013: -$1.44M2014: -$17.83M2015: -$40.41M2016: -$6.44M2017: -$6.29M2018: -$12.63M2019: -$26.44M2020: -$26.07M2021: -$6.34M2022: -$3.62M2023: $3.96M2024: $8.11M2025: $4.08M$4.08M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$4.08M-49.6%2024$8.11M+105.0%2023$3.96M+209.4%2022-$3.62M+42.9%2021-$6.34M+75.7%2020-$26.07M+1.4%2019-$26.44M-109.3%2018-$12.63M-100.7%2017-$6.29M+2.3%2016-$6.44M+84.1%2015-$40.41M-126.7%2014-$17.83M-1140.5%2013-$1.44M+94.3%2012-$25.23M-436.6%2011-$4.70M+31.9%2010-$6.90M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share